baber/WOPTO huggingface dataset:
Patent NZ-529496-A (NZ)
Title: Potential cardiotoxicity of compounds predicted based on the interaction of astemizole with the HERG (human ether-a-go-go-related gene) potassium channel
Inventor: HEYLEN GODELIEVE IRMA CHRISTIN
IPC: C12Q1/68
Filed: 2002-07-02
Abstract: Assays and kits are provided for the screening of test compounds for their capability to induce cardiotoxicity in a subject. The assays and kits are based on the finding that the interaction of astemizole with the HERG (Human Ether-a-go-go-Related Gene) potassium channel can be exploited to predict cardiotoxicity of compounds during the development of new therapeutics and other agents. Figure 1 A shows the saturation binding of [3H]-astemizole to cell membrane preparations of HEK293 cells stably transfected with the HERG channel cDNA. TB represents Total Binding measured, NSB represents Non Specific Binding measured and SB represents Specific Binding measured.
Patent NZ-529519-A (NZ)
Title: Phosphotriesterase from agrobacterium radiobacter P230
Inventor: HORNE IRENE
IPC: C12N1/20
Filed: 2002-05-15
Abstract: A polypeptide comprising the sequence selected from SEQ ID NOs:1-4 which is capable of hydrolyzing an organophosphate molecule is described. Fusion polypeptides, vectors, host cells, processes for preparing the polypeptide and polynucleotides are also described. Also described is an isolated strain of Agrobacterium radiobacter deposited under NM01/21112 is also described. Compositions comprising the bacterium or polypeptide can be used to hydrolyse an organophosphate in a sample.
Patent NZ-530328-A (NZ)
Title: Side scattering polymer light guide and method of manufacture
Inventor: FRANKLIN JAMES BRUCE
IPC: B29C43/52
Filed: 2002-05-21
Abstract: A side scattering light guide (10) for emitting light comprises a substantially transparent polymer core (12) surrounded by a transparent or translucent polymer cladding (14). The core (12) includes a light scattering additive (20) arranged to scatter light within the core so that at least some of the light passes through the cladding (14) to be emitted from the light guide (10). The light scattering additive (20) yields a high ratio of forward to backward scattering and is preferably in the form of diffuser particles. The type, density, concentration and/or refractive index of the light scattering additive may be selected to achieve the desired side scattering characteristics. A method of manufacturing the side scattering light guide (10) is also disclosed.
Patent NZ-535962-A (NZ)
Title: Extracting power from a fluid flow
Inventor: ROCHESTER GEOFFREY KENNETH
IPC: F03B13/26
Filed: 2003-03-19
Abstract: An apparatus for extracting power from a fluid flow (110) comprises a fluid driveable engine (120), a conduit (140), disposed to enable fluid communication between a portion of the fluid flow (110), the fluid driveable engine (120) and a transmission fluid, the fluid in the fluid flow and the transmission fluid being different fluids and the portion of the fluid flow being at a lower pressure than the transmission fluid by virtue of its flow rate, thus causing the transmission fluid to be drawn through the conduit to become entrained in the fluid flow, the fluid driveable engine being arranged such that the flow of the transmission fluid along the conduit acts to drive the fluid driveable engine (120).
Patent NZ-541258-A (NZ)
Title: High-speed apparatus and method for forming inflated chambers
Filed: 2005-07-14
Abstract: An apparatus and a method for inflating an inflatable web wherein an inflatable web is conveyed along a path of travel with an inflation element positioned between unsealed edges of the web and proximate the inflation ports of the web's inflatable chambers. A tracking sensor is used to detect the transverse position of the web with respect to the inflation element. A web tracking system is employed to continually adjust the transverse position of the web to maintain it within a predetermined range with respect to the inflation element. In this manner, the consistency of inflation of the inflatable chambers is improved.
Patent NZ-543074-A (NZ)
Title: Benzothiazole derivatives as adenosine receptor ligands
Inventor: FLOHR ALEXANDER
IPC: C07D417/14
Filed: 2004-05-14
Abstract: Disclosed are compounds of formula I, wherein R1 is 1,4-dioxepanyl or tetrahydropyran-4-yl and the remaining substituents are as defined in the specification. The compounds are adenosine A2A receptor ligands useful in the treatment of diseases of the central nervous system including Alzheimer's disease, depression, drug addiction, neuroprotection, Parkinson's disease or attention deficit hyperactivity disorder (ADHD).
Patent NZ-543208-A (NZ)
Title: Interactive customer operated terminal for creating orders for goods or services
Inventor: HO TIEN XAM
IPC: G06Q30/00
Filed: 2004-03-01
Abstract: A method of processing an order at an outlet for goods or services is provided. The method comprises the steps of: presenting a menu of available items at a customer operated terminal, receiving a selection of items on the menu from the customer at the terminal, providing an order document to the customer including an indication of the selected items and their cost, receiving the order document from the customer at a serving station, receiving payment from the customer for the cost of the order, preparing the selected items for the customer only after receipt of the order document, and providing the selected items to the customer to meet the order.
Patent NZ-543902-A (NZ)
Title: Bait station
Inventor: CORLISS PHILIP
Filed: 2005-12-01
Abstract: A possum bait station of moulded plastic includes a container 11 for the poison bait that only possums (rather than birds) should be able to access via the open top 13a and a rotating lid closure 12 that is biased closed by the spring 15 to cover the opening. A possum perched atop the station is clever enough to be able to lean its weight on the lever handle 20 extending from the lid to open the lid against the bias of the spring to retrieve the bait out of the container. The station may be mounted to a tree or post by mounting 24. The lid not only keeps animals other than possums from the bait but also protects the interior of the container from rain and debris.
Patent NZ-546057-A (NZ)
Title: Tubulin inhibitors
Inventor: BURNS CHRISTOPHER JOHN
IPC: C07D403/12
Filed: 2004-12-03
Abstract: Disclosed are compounds represented by Fomula (I), (II), (III) and (V), or pharmaceutically acceptable prodrugs, salts, hydrates, solvates, crystal forms or diastereomers thereof wherein the substituents are listed in the specification. These compounds can be used in the manufacture of a medicament for modulating microtubule polymerisation and in the treatment of associated disease states.
Patent NZ-547456-A (NZ)
Title: Process for increasing the refiner production rate and/or decreasing the specific energy of pulping wood by applying a lubricant solution or a carrier/frictionizer solution
Inventor: LAURINT MARK EDWARD
IPC: D21B1/02
Filed: 2004-12-03
Abstract: Disclosed is a process for increasing the production rate and/or reducing specific energy of a refiner for a freeness target comprising: (a) applying a lubricant solution to an amount of wood chips prior to delivery into a refining area; and (b) delivering the wood chips to a refiner.
Patent NZ-548931-A (NZ)
Title: Stabilised formulation of moxidectin
Inventor: GLIDDON MICHAEL JOHN
Filed: 2006-08-04
Abstract: Disclosed is an oral drench composition including moxidectin and a stabilising agent selected from the group consisting of: dilauryl thiodipropionate; monothioglycerol; potassium metabisulfite; sodium formaldehyde sulfoxylate; sodium thiosulfate; thioglycolic acid; thiourea; ascorbyl palmitate; cysteine or a salt thereof; ethoxyquin; isoascorbic acid; ethylene diamine tetra-acetic acid or a salt thereof; potassium bisulfate; sodium metabisulfite; sodium bisulfite; thiosorbitol; fumaric acid; malic acid; and a mixture thereof, with the proviso that, when the composition contains two active ingredients, the second active ingredient is not praziquantel. A method for stabilising an oral drench veterinary composition including moxidectin as an active ingredient is also disclosed, wherein an effective amount of the selected stabilising agent is added to said composition. These compositions are suitable for the treatment, prevention or control of helminth, acarid or arthropod endo- or ectoparasitic infection or infestation in a non-human animal.
Patent NZ-553960-A (NZ)
Title: Water bowl
Inventor: GIBSON DAVID
IPC: A01K7/00
Filed: 2007-03-20
Abstract: An animal water bowl (100) comprising a water reservoir (101), the reservoir including an external recess forming a water basin (102); an aperture (105) for providing water flow between the reservoir and the basin; and a valve assembly (111, 112) for controlling the water flow through the aperture. The valve assembly is adapted such that the basin may be self-replenishing with water from the reservoir. The reservoir, aperture and water basin are arranged such that in use, when the valve of the valve assembly is open, the pressure-equilibrium within the reservoir is capable of maintaining the water level in the reservoir above the water level in the basin.
Patent NZ-554100-A (NZ)
Title: Web based telephony access method
Inventor: CLARKE RICHARD LLOYDE
IPC: H04M3/42
Filed: 2005-10-05
Abstract: A telephony contact identifier conversion system that enables a user to initiate telephony contact between the user and a target using a connection between a user device and target device is disclosed. The system includes: a conversion application that receives a telephony contact identifier from a page of data requested by the user. The telephony contact identifier is associated with a target. The conversion application converts the telephony contact identifier into an action initiator and modifies the page to present the action initiator to a user. The action initiator initiates upon user initiation a telephony connection between the user device and the target device.
Patent NZ-564301-A (NZ)
Title: Bone fixator
Inventor: MOORCROFT CHRISTOPHER IAN
IPC: A61B17/17
Filed: 2006-06-07
Abstract: An external bone fixator 10 includes a one piece support beam 11 without articulated joints that has opposed end blocks 12, 13 for the reception of bone screws 30 to attach the respective ends of the support beam to opposed sides of the fracture of the bone 50. The support beam is configured to allow predetermined relative movement between the respective ends to allow relative movement between the fractured ends of the bone to trigger and encourage callus formation between the fractured ends whilst maintaining the alignment of the bone ends.
Patent NZ-564642-A (NZ)
Title: Grating-based sensor combining label-free binding detection and fluorescence amplification and readout system for sensor
Inventor: CUNNINGHAM BRIAN T
IPC: G01N21/55
Filed: 2006-07-20
Abstract: Disclosed is an optical sensor for testing samples. The sensor comprises a substrate with a periodic surface grating structure. The structure is constructed in a way that makes optical interrogation with light possible in both in an evanescent resonance (ER) mode and a label-free detection mode.
Patent NZ-573913-A (NZ)
Title: Treating al/zn-based alloy coated products
Inventor: LIU QIYANG
IPC: C23C2/06
Filed: 2007-05-24
Abstract: Disclosed is a method of improving the hardness and / or corrosion resistance of a hot dip Al/Zn-based alloy galvanised coated steel product; said method includes the steps of: (a) heating the alloy coating to at least partially melt the alloy coating, and (b) very rapid cooling of the alloy coating at a cooling rate of at least 100°C/s by using the substrate as a heat sink, and forming a modified crystalline microstructure of the alloy coating as the coating solidifies.
Patent NZ-579098-A (NZ)
Title: Formulations for cancer treatment
Inventor: OSSOVSKAYA VALERIA
IPC: A61K9/48
Filed: 2008-01-16
Abstract: Disclosed herein is a pharmaceutical composition comprising a compound of formula (Ia) or a pharmaceutically acceptable salt thereof, wherein the substituents are as defined with in the specification and wherein at least two of the five substituents are always hydrogen, at least one of the five is always nitro and at least one substituent positioned adjacent to a nitro is always iodo; a buffer; and a beta-cyclodextrin. Also disclosed is the used of said composition in the treatment of cancer.
Patent NZ-584880-A (NZ)
Title: Device for indicating a specific time period has passed by the mixing of two chemicals to create a new coloration.
Inventor: ROBINSON JOHN
IPC: G01K3/04
Filed: 2008-09-26
Abstract: Disclosed is a time indicator device for perishable products such as food and pharmaceuticals. The device comprises first and second interconnected reservoirs containing first and second liquids respectively, a first barrier being provided between the first and second liquids to prevent the liquids mixing. The first barrier is connected via a conduit to a third reservoir containing a third liquid which is adapted to pass along the conduit over a first predetermined time period and to effect removal of the first barrier upon contact to facilitate mixing of the first and second liquids. Upon mixing of the first and second liquids, a different colour mixture is formed to the second liquid's colour prior to mixing and thereby provide an indication of when the first predetermined time period has elapsed. A second barrier is provided between the third reservoir and the conduit. The second barrier is adapted such that, upon removal, the first predetermined time period is initiated by permitting the passage of the third liquid along the conduit. The second barrier is adapted to be removable as a result of opening a product to which the device is attached or as a result of attaching the device to a product.
Patent NZ-589001-A (NZ)
Title: A lid with a polyethylene sealing resin layer, a metal foil layer, and a weakened layer
Inventor: GOTOH MASASHI
IPC: B32B15/20
Filed: 2009-04-24
Abstract: 589001 The disclosure relates to a lid with barrier property having highly improved barrier property, sealing ability for cups, and ease of opening in comparison with the conventional products. The innermost layer is a resin layer including a polyethylene sealant layer, and a metal foil layer is attached to the outside of the resin layer of the innermost layer via an adhesive layer. The innermost layer is provided with a plurality of weakened portions extending radially from the center. The weakened portions facilitate tearing the innermost layer and also the metal foil layer, thereby facilitating opening of the lid.
Patent NZ-591050-A (NZ)
Title: A container to disinfect a sponge wherein the sponge an be soaked and then squeezed out
Inventor: PLEWRIGHT GLEN
IPC: A61L2/12
Filed: 2009-07-20
Abstract: A steriliser unit (10) for sterilising an absorbent body (30), such as a sponge is disclosed. The steriliser unit firstly comprises a container (12) for holding a disinfectant, the container providing a soak position (22) and a discharge position (26). The steriliser unit also includes a discharge unit (14) for cooperation with the container, the discharge unit defines a compression compartment (28) in which the absorbent body can be held. The discharge unit is further movable between a release position in which the absorbent body can be located within the compression compartment and a compression position in which the discharge unit will apply a compressive force on the absorbent body inside the compression compartment. In use the compression compartment can be located within the soak position of the container when the discharge unit is located in its release position, thereby allowing the absorbent body to absorb an amount of disinfectant. The discharge unit can also be moved to its compression position when the compression compartment is located in the discharge position of the container, such that the absorbent body is compressed to squeeze out the disinfectant which it had absorbed when it was located inside the soak position of the container. This feature allows the user to place the steriliser unit into a microwave, for example, to heat the disinfectant while the sponge is in the disinfectant, and then squeeze out the hot disinfectant without risk of harm from the hot liquid.
Patent NZ-593113-A (NZ)
Title: Power grid outage and fault condition management
Inventor: TAFT JEFFREY D
IPC: G05B19/042
Filed: 2009-12-14
Abstract: 593113 Disclosed is a computer implemented method of managing an outage condition associated with at least one portion of a power grid. A plurality of event messages are received that are indicative of a condition associated with the at least one portion of the power grid. Using at least one processor, a determination is made whether at least one of the plurality of event messages is indicative of an outage condition associated with the at least one portion of the power grid. At least a portion of grid state data is retrieved and is representative of current demand conditions of the power grid. Also retrieved is at least a portion of connectivity data which is representative of a physical configuration of the power grid. Using the at least one processor, presence of the outage condition is verified based on the grid state data and connectivity data. Using the at least one processor, at least one message is generated which is representative of the outage condition and is configured to provide notification of the outage condition. At least one suspension message is received to suspend processing the plurality of event messages from at least one device in the at least one portion of the power grid where the suspension message is indicative of a detected tampering of the at least one device. The processing of the event messages received is suspended from the at least one device in response to receiving the at least one suspension message.
Patent NZ-597895-A (NZ)
Title: Amide derivative
Inventor: YAMANOI SHIGEO
IPC: A61K31/4245
Filed: 2010-08-04
Abstract: A heterocyclic amide derivative comprising four non-condensed rings as shown in formula I such as a 3-(4-(aminocarbonylaryl)-1,3-oxazole-2-yl)methyloxy aryl-1,2,4-oxadiazole derivative or a 3-(3-(aminocarbonylaryl)-1,2,4-oxadiazole-5-yl)methyloxy aryl-1,2,4-oxadiazole derivative.
Patent NZ-611630-A (NZ)
Title: (1,2,4)triazolo[4,3-a]quinoxaline derivatives as inhibitors of phosphodiesterases
Inventor: LANKAU HANS-JOACHIM
IPC: C07D487/04
Filed: 2012-01-31
Abstract: Disclosed are 1-aryl-[1,2,4]triazolo[4,3-a]quinoxaline derivatives as represented by the general formula (I), or a pharmaceutically acceptable salt thereof; wherein: R1 represents an ortho-substituted phenyl or pyridyl ring; R2 represents hydrogen or optionally substituted alkyl; R3, R4, R5 and R6 are independently selected from hydrogen, halogen, optionally substituted alkyl, optionally substituted cycloalkyl, cyano, hydroxy, optionally substituted alkoxy or optionally substituted cycloalkoxy, and wherein the remaining substituents are as defined herein. Representative compounds include 8-chloro-1-(2-chloro-phenyl)-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline, 8-chloro-4-methyl-1-o-tolyl-[1,2,4]triazolo[4,3-a]quinoxaline, 8-chloro-1-(2-methoxy-phenyl)-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline, 8-chloro-1-(2,5-dichlorophenyl)-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline, 8-chloro-1-(2-chloro-5-methoxy-phenyl)-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline, 7-chloro-1-(2,6-difluorophenyl)-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline, 1-(2-chloro-phenyl)-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline, 1-(2-chloro-6-fluoro-phenyl)-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline, 4-methyl-3-(4-methyl-[1,2,4]triazolo[4,3-a]quinoxalin-1-yl)-phenol, 4-chloro-3-(4-methyl-[1,2,4]triazolo[4,3-a]quinoxalin-1-yl)-phenol, 1-(2-chloro-phenyl)-8-fluoro-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline, 1-(2-chloro-phenyl)-4-methyl-8-trifluoromethyl-[1,2,4]triazolo[4,3-a]quinoxaline, 1-(2,6-difluoro-phenyl)-4-methyl-7-trifluoromethyl-[1,2,4]triazolo[4,3-a]quinoxaline, 1-(2-chloro-phenyl)-7-methoxy-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline, 1-(2-chloro-phenyl)-7-[2-(3,4-dimethoxy-phenyl)-ethoxy]-4-methyl-[1,2,4]triazolo[4,3-a]quinoxaline, 1-(2-chlorophenyl)-4-methyl-8-(quinolin-2-ylmethoxy)-[1,2,4]triazolo[4,3-a]quinoxaline, 8-bromo-1-(2-chlorophenyl)-4-methy[1,2,4]triazolo[4,3-a]quinoxaline and 4-chloro-3-(8-chloro-4-methyl-[1,2,4]triazolo[4,3-a]quinoxalin-1-yl)phenol. Also disclosed is a medicament composition comprising a compound as defined above for the treatment of humans, and particularly for treating conditions such as Alzheimer’s disease, obesity, type II diabetes, metabolic syndrome, glucose intolerance, mental disorders, dementia, mental retardation, anxiety disorders, attention deficit hyperactivity syndrome (ADHD), schizophrenia, mental and behavioural disorders due to psychoactive substance use, extrapyramidal and movement disorders, epilepsy and sexual dysfunction.
Patent NZ-620322-A (NZ)
Title: A method for estimating electricity consumption cost based on data received from an electricity meter
Inventor: DENG PAUL PENG
IPC: G06F17/40
Filed: 2012-10-25
Abstract: 620322 Disclosed is a device for estimating electricity consumption cost from a current time to an end of a current billing period based on usage data received from an electricity meter. The device comprises a database for storing electricity usage data received from the electricity meter, and a computer processor. The computer processor is configured to calculate, based on the retrieved usage data, an average hourly electricity consumption cost for a predetermined number of previous days. The processor is also configured to calculate, based on the retrieved usage data, an average daily electricity consumption cost for the predetermined number of previous days. The processor then calculates the number of days remaining until the end of the current billing period and multiplies the number of days remaining with the average daily electricity consumption cost to provide an estimate of electricity consumption cost for remaining days of the current billing period. The processor also subtracts the hour of the current time from twenty-four and multiplies the result with the average hourly electricity consumption cost to provide an estimate of electricity consumption cost for remaining hours in the current day. The processor is configured to then add the estimate of electricity consumption cost for remaining hours in the current day to the estimate of electricity consumption cost for remaining days of the current billing period to provide an estimated electricity consumption cost from the current time to an end of the current billing period. This estimated cost may be presented to a user on a display of the device.
Patent NZ-628449-A (NZ)
Title: Neisseria meningitidis compositions and methods thereof
Inventor: ANDERSON ANNALIESA SYBIL
IPC: C07K16/12
Filed: 2013-03-06
Abstract: Disclosed is an isolated ORF2086 polypeptide consisting of the amino acid sequence SEQ ID NO: 71. Also disclosed is the use of an immunogenic composition comprising an isolated non-lipidated, non-pyruvylated ORF2086 polypeptide having the amino acid sequence consisting of SEQ ID NO: 71 in the manufacture of a medicament for eliciting a bactericidal antibody against Neisseria meningitidis serogroup C in a mammal.